Archives: News

Grouped Alto applications are final FDA submission for deemed products, representing both Vuse and VELO portfolios Reynolds completes 2020 deemed product PMTA submissions for one of the broadest portfolios in the industry Reynolds has provided the FDA with more than 530,000 pages of scientific data for review as part of all PMTA applications submitted More … Continued

VELO pouch is second group of PMTAs for VELO products, and completes current VELO brand PMTA submissions  WINSTON-SALEM, NC. September 1, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO pouches. … Continued

FDA applications are a first for VELO’s dissolvable nicotine lozenges WINSTON-SALEM, N.C. – August 24, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO dissolvable nicotine lozenges. A grant of these … Continued

Reynolds stands against racism and discrimination in all forms, and we condemn all acts of hate against African Americans and other groups. Our recruitment of a diverse workforce in order to create a culture of inclusion where employees are treated equally will continue to be one of our top priorities. We have a long way … Continued

Vuse Vibe and Vuse Ciro join Reynolds’ Prior Vuse Solo Submission to FDA WINSTON-SALEM, N.C. – April 15, 2020 – Reynolds American (“Reynolds”) announced today that it has submitted two new Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”). Reynolds is seeking marketing orders for their Vuse Vibe and Vuse Ciro … Continued

Potential vaccine in development for COVID-19 using new, fast-growing tobacco plant technology – pre-clinical testing under way Tobacco plants offer the potential for faster and safer vaccine development compared to conventional methods Potential to manufacture 1-3 million doses of vaccine per week April 1, 2020: BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for … Continued

Reynolds American Inc. Group earns top marks in 2020 Corporate Equality Index, designated a “Best Place to Work for LGBTQ Equality” Comprehensive parental leave, employee resource groups and CEO pledge to promote diversity and inclusion among reasons RAI Group scored 100% on Human Rights Campaign Foundation’s annual assessment WINSTON-SALEM, N.C. – Jan. 22, 2020 – The … Continued

First-of-its-Kind Filing for VUSE Products WINSTON-SALEM, N.C. – Nov. 27, 2019 – Today, Reynolds American Inc. (“RAI”) announced that the recently-submitted Premarket Tobacco Product Application (“PMTA”) for VUSE vapor products has been filed by the Food and Drug Administration (“FDA”) for substantive scientific review, moving the application one step further through the review process. “This … Continued

Variety of RAI Group programs and policies – comprehensive parental leave, employee resource groups and Women of Transformation, among others – promote diversity and inclusion WINSTON-SALEM, N.C. – Oct. 25, 2019 – Ricardo Oberlander, president and chief executive officer (CEO) of Reynolds American Inc. (RAI) has signed the pledge for CEO Action for Diversity & Inclusion™, joining … Continued

WINSTON-SALEM, N.C. – Oct. 11, 2019 – Reynolds American Inc. (“Reynolds”) today announced submission of a Premarket Tobacco Product Application (“PMTA”) through one of its subsidiaries to the U.S. Food and Drug Administration (FDA) seeking orders authorizing the marketing of VUSE Electronic Nicotine Delivery Systems (ENDS) products. VUSE products offer a cartridge-based vapor system intended for adult … Continued